Skip to content

Haemonetics HAE Acquired Intangible Amortization

Acquired Intangible Amortization at other companies

SLM logo
SLMSLM
$740K-27.5%
Diodes logo
DiodesDIOD
$3.94M-32.3%
Synaptics logo
SynapticsSYNA
$1.9M-57.8%
Synaptics logo
SynapticsSYNA
$26M-16.1%
SLM logo
SLMSLM
$740K-27.5%
Sotera Health logo
Sotera HealthSHC
$3.03M-80.2%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept hae:AmortizationOfAcquiredIntangibleAssets.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's acquired intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's acquired intangible amortization?
Haemonetics (HAE) reported acquired intangible amortization of $10.49M in Q1 2026.
How has Haemonetics's acquired intangible amortization changed year-over-year?
Haemonetics's acquired intangible amortization decreased by 7.1% year-over-year, from $11.3M to $10.49M.
What is the long-term trend for Haemonetics's acquired intangible amortization?
Over 4 years (2022 to 2026), Haemonetics's acquired intangible amortization has grown at a -1.9% compound annual growth rate (CAGR), from $47.41M to $44M.
What does acquired intangible amortization mean?
This metric represents the systematic allocation of the cost of intangible assets acquired through business combinations over their estimated useful lives. It reflects the non-cash expense associated with the consumption of economic benefits from assets such as patents, customer relationships, and trademarks. Investors monitor this to distinguish between operational cash performance and accounting charges related to historical M&A activity.